Cks1, as a cell control molecule, has been identified as a potential molecular target for cancer treatment since its silencing resulted in G2/M arrest and apoptosis of lung cancer cells without affecting normal fibroblasts [37] and growth inhibition of cells of oral squamous carcinoma [38]. Here, CKS1B is linked to lung cancer.